Drug Trial Radar · NCT05292495
A Trial of HR17031 Injection With Renal Insufficiency
Last checked: Nov 19, 2026Latest source record: May 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
Oct 12, 2022
Primary completion
Apr 10, 2024
Study completion Apr 10, 2024
Sponsor
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Mar 23, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study used a single-dose, open design to compare the pharmacokinetics of subjects with mild, moderate and severe renal insufficiency and end-stage renal disease and subjects with normal renal function.
Conditions
- Improved Glycemic Control in Patients With Type 2 Diabetes
Interventions
HR17031 injectionDrug
HR17031 injection; administered subcutaneously.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pharmacokinetics parameters of INS068 and SHR20004: CmaxTime frame: Based on pre-dose, 2-96 hours post-dose sampling times
- Pharmacokinetics parameters of INS068 and SHR20004: AUC0-tTime frame: Based on pre-dose, 2-96 hours post-dose sampling times
- Pharmacokinetics parameters of INS068 and SHR20004: AUC0-infTime frame: Based on pre-dose, 2-96 hours post-dose sampling times
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Peking University First Hospital
Beijing, Beijing Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.